Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.

Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. Leuk Lymphoma. 2009 Oct; 50(10):1589-96.

View in: PubMed

subject areas

Adult
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antigens, CD
Antigens, Neoplasm
Anti-Infective Agents
Bone Marrow Diseases
CD52 Antigen
Cohort Studies
Cytomegalovirus Infections
Feasibility Studies
Female
Glycoproteins
Humans
Hypotension
Infusions, Intravenous
Injections, Subcutaneous
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Neoplasm Proteins
Survival Analysis
Vidarabine

authors with profiles

Richard A. Larson